Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Methods for Prevention of Urinary Tract Infection Following Botox Injection

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion criteria:~* ≥ 18 years of age~* Medication refractory OAB, identified per American Urological Association guidelines~Exclusion criteria:~* Post void residual urine \>150ml on two occasions~* Untreated, symptomatic UTI~* Comorbid neurological conditions, including spinal cord injury, systemic neurologic illnesses (i.e. multiple sclerosis, Parkinson's disease) or central nervous system disease (i.e. brain tumor, stroke)~* Prior pelvic irradiation~* Current or prior bladder malignancy~* Hematuria lacking a clinically appropriate evaluation~* Chronic indwelling or intermittent catheterization

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Periprocedural Antibiotics Only (Type: EXPERIMENTAL): Patients receive a one-time dose of antibiotics at the time of injection, prior to injection.
- Extended Antibiotics (Type: EXPERIMENTAL): Patients receive a peri-procedural dose of antibiotics and an extended (3-day) course of antibiotics to be taken post-procedurally.

Based on this trial design, predict the completion outcome and termination type (if applicable).